Efficacy and safety of naotaifang capsules for hypertensive cerebral small vessel disease: Study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial.
Fang R, Hu H, Zhou Y, Wang S, Mei Z, She R, Peng X, Jiang Q, Wang X, Xie L, Lin H, Meng P, Zhang K, Wang W, Xie Y, Liu L, Tong J, Wu D, Luo Y, Liu C, Lu Y, Yu S, Cheng S, Xu L, Fang Z, Shang H, Ge J.
Fang R, et al. Among authors: wang x, wang w, wang s.
Front Pharmacol. 2023 Jan 6;13:967457. doi: 10.3389/fphar.2022.967457. eCollection 2022.
Front Pharmacol. 2023.
PMID: 36686705
Free PMC article.